Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants.

Stajich GV, Lopez GP, Harry SW, Sexson WR.

J Pediatr. 2000 May;136(5):679-81.

PMID:
10802503
2.
3.

Neonate exposure to thimerosal mercury from hepatitis B vaccines.

Dórea JG, Marques RC, Brandão KG.

Am J Perinatol. 2009 Aug;26(7):523-7. doi: 10.1055/s-0029-1215431. Epub 2009 Mar 12.

PMID:
19283656
5.

Impact of the thimerosal controversy on hepatitis B vaccine coverage of infants born to women of unknown hepatitis B surface antigen status in Michigan.

Biroscak BJ, Fiore AE, Fasano N, Fineis P, Collins MP, Stoltman G.

Pediatrics. 2003 Jun;111(6 Pt 1):e645-9.

PMID:
12777580
6.
7.

Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines.

Pichichero ME, Gentile A, Giglio N, Umido V, Clarkson T, Cernichiari E, Zareba G, Gotelli C, Gotelli M, Yan L, Treanor J.

Pediatrics. 2008 Feb;121(2):e208-14. doi: 10.1542/peds.2006-3363.

PMID:
18245396
8.

Impact of the 1999 AAP/USPHS joint statement on thimerosal in vaccines on infant hepatitis B vaccination practices.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2001 Feb 16;50(6):94-7.

9.

Effect of thimerosal recommendations on hospitals' neonatal hepatitis B vaccination policies.

Brayden RM, Pearson KA, Jones JS, Renfrew BL, Berman S.

J Pediatr. 2001 May;138(5):752-5.

PMID:
11343056
10.

Hepatitis B vaccination: long-term follow-up of the immune response of preterm infants and comparison of two vaccination protocols.

Linder N, Vishne TH, Levin E, Handsher R, Fink-Kremer I, Waldman D, Levine A, Ashkenazi S, Sirota L.

Infection. 2002 Jun;30(3):136-9.

PMID:
12120937
11.

Early mercury exposure (with ethylmercury) could include 3-day olds: is that the case in China?

Dórea JG.

Environ Res. 2008 Mar;106(3):420; discussion 421-2. doi: 10.1016/j.envres.2007.12.001. Epub 2008 Jan 25. No abstract available.

PMID:
18221937
12.

The evidence for the safety of thiomersal in newborn and infant vaccines.

Clements CJ.

Vaccine. 2004 May 7;22(15-16):1854-61. Review.

PMID:
15121295
13.

Time of perinatal immunization, thimerosal exposure and neurodevelopment at 6 months in breastfed infants.

Marques RC, Dórea JG, Manzatto AG, Bastos WR, Bernardi JV, Malm O.

Acta Paediatr. 2007 Jun;96(6):864-8. Epub 2007 Apr 27.

PMID:
17465985
14.

Hepatitis B vaccination practices in hospital newborn nurseries before and after changes in vaccination recommendations.

Clark SJ, Cabana MD, Malik T, Yusuf H, Freed GL.

Arch Pediatr Adolesc Med. 2001 Aug;155(8):915-20.

PMID:
11483119
15.

[Premature infants and hepatitis B vaccination. Study Group Prevention Neonatal Hepatitis B].

Del Canho R, Grosheide PM, Gerards LJ, Heijtink RA, Schalm SW.

Tijdschr Kindergeneeskd. 1992 Aug;60(4):105-11. Dutch.

PMID:
1440551
16.

Mercury levels in premature and low birth weight newborn infants after receipt of thimerosal-containing vaccines.

Pichichero ME, Gentile A, Giglio N, Alonso MM, Fernandez Mentaberri MV, Zareba G, Clarkson T, Gotelli C, Gotelli M, Yan L, Treanor J.

J Pediatr. 2009 Oct;155(4):495-9. doi: 10.1016/j.jpeds.2009.04.011. Epub 2009 Jun 26.

17.

An assessment of thimerosal use in childhood vaccines.

Ball LK, Ball R, Pratt RD.

Pediatrics. 2001 May;107(5):1147-54. Review.

PMID:
11331700
18.

[Mercury in vaccines].

Hessel L.

Bull Acad Natl Med. 2003;187(8):1501-10. Review. French.

PMID:
15146581
20.

Immunogenicity of hepatitis B vaccine in preterm and full term infants vaccinated within the first week of life.

Freitas da Motta MS, Mussi-Pinhata MM, Jorge SM, Tachibana Yoshida CF, Sandoval de Souza CB.

Vaccine. 2002 Feb 22;20(11-12):1557-62.

PMID:
11858862
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk